Whitehawk Therapeutics Statistics
Total Valuation
WHWK has a market cap or net worth of $117.35 million. The enterprise value is -$45.25 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WHWK has 47.13 million shares outstanding. The number of shares has increased by 90.13% in one year.
| Current Share Class | 47.13M |
| Shares Outstanding | 47.13M |
| Shares Change (YoY) | +90.13% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 7.86% |
| Owned by Institutions (%) | 19.98% |
| Float | 18.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.89 |
| Forward PS | n/a |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.76
| Current Ratio | 16.76 |
| Quick Ratio | 16.51 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.82% and return on invested capital (ROIC) is -59.73%.
| Return on Equity (ROE) | -13.82% |
| Return on Assets (ROA) | -53.65% |
| Return on Invested Capital (ROIC) | -59.73% |
| Return on Capital Employed (ROCE) | -69.01% |
| Revenue Per Employee | $359,600 |
| Profits Per Employee | -$390,450 |
| Employee Count | 40 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.63% in the last 52 weeks. The beta is 0.69, so WHWK's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +1.63% |
| 50-Day Moving Average | 2.21 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 59.66 |
| Average Volume (20 Days) | 193,684 |
Short Selling Information
The latest short interest is 978,190, so 2.08% of the outstanding shares have been sold short.
| Short Interest | 978,190 |
| Short Previous Month | 1.03M |
| Short % of Shares Out | 2.08% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 2.61 |
Income Statement
In the last 12 months, WHWK had revenue of $14.38 million and -$15.62 million in losses. Loss per share was -$0.31.
| Revenue | 14.38M |
| Gross Profit | -73.46M |
| Operating Income | -108.46M |
| Pretax Income | -15.62M |
| Net Income | -15.62M |
| EBITDA | -108.34M |
| EBIT | -108.46M |
| Loss Per Share | -$0.31 |
Full Income Statement Balance Sheet
The company has $162.60 million in cash and n/a in debt, giving a net cash position of $162.60 million or $3.45 per share.
| Cash & Cash Equivalents | 162.60M |
| Total Debt | n/a |
| Net Cash | 162.60M |
| Net Cash Per Share | $3.45 |
| Equity (Book Value) | 157.17M |
| Book Value Per Share | 3.33 |
| Working Capital | 155.19M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$95.25 million and capital expenditures -$738,000, giving a free cash flow of -$95.99 million.
| Operating Cash Flow | -95.25M |
| Capital Expenditures | -738,000 |
| Free Cash Flow | -95.99M |
| FCF Per Share | -$2.04 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -754.05% |
| Pretax Margin | -108.58% |
| Profit Margin | -108.58% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |